Virtual Naval Hospital

Emergency War Surgery NATO Handbook: Part II: Response of the Body to Wounding: Chapter XI: Infection

Table 7

United States Department of Defense
Peer Review Status: Internally Peer Reviewed


Table 7. - Choice, Mode of Action, Spectrum, and Dosage of Antibiotic Agents

Agent

Mode of Action

Antibacterial Spectrum of Clinical Importance

Dosage

Penicillin G

Bactericidal; interferes with bacterial cell wall synthesis

Streptococci, Pneumococci Clostridia, Neisseriae, Corynebacteria, Pasteurella multocida, Actinomyces, Treponema, Listeria

30 mil units IV/day every 2-4 hours

Ampicillin

Bactericidal; same as above

Hemophilus influenzae, Proteus mirabilis, Salmonallae, Shigellae and some E. coli. Gram-positive organisms as with Penicillin G

8 gm IV/day every 6 hours

Gentamicin

Bacteriostatic; inhibition of bacterial protein synthesis

Klebsiella sp., Aerobacter sp., Pseudomonas aeruginosa, Serratia, indole positive Proteus sp., some Methicillin-resistant Staphylococci

5 mg/kg/day every 8-12 hours

Metronidazole

Bacteriocidal

Gram-negative anaerobes especially Bacteriodes fragilis. Also effective against several protozoa.

2 gm IV/day every 4 hours

Cefoxitin (2nd generation cephalosporin)

Cell wall synthesis inhibitors; stable to staphylococcal beta lactamases

Same as above plus Bacteroides fragilis; not active against Enterobacter spp.

12 gm IV/day every 6 hours

Clindamycin

Bacteriostatic; inhibits protein synthesis

Gram-positive and Gram-negative anaerobes, Gram-positive aerobic cocci, Streptococcus faecalis, Clostridia

1200-2700 mg IV/day every 6-8 hours

Next Page | Previous Page | Section Top | Title Page


Virtual Naval Hospital Home | Help | Search | Outline | Disclaimer | Comments
cartographer@vnh.org

All contents copyright © 1997-2000 The University of Iowa. All rights reserved.

URL: http://www.vnh.org/

http://www.vnh.org/EWSurg/ch11/11Table7.html
Modified: Wed Jan 5 11:06:51 2000
Displayed: Sun May 14 10:11:43 2000